Impact Biomedical Announces SEC Effectiveness of Form F-4 for Merger with Zoar Limited

Filing content

Impact Biomedical announced that the SEC declared the Form F-4 registration statement for its merger with Zoar Limited effective on October 23, 2026. A special meeting of stockholders to vote on the merger is scheduled for November 13, 2026.